Bernstein Analyst on UnitedHealth Group: Underlying Value and Future Outlook

UnitedHealth Group's Value Proposition

• 💡 Despite facing numerous headwinds, UnitedHealth Group's stock is considered to have significant underlying assets that are highly valuable.
• 🎯 The company's biggest and most important unit, Optum Health, is poised for growth as value-based care contracts are expected to expand from 15% to 100% of the market.
• 🚀 A turnaround is anticipated in the Medicare and Medicaid businesses over the next couple of years, which should benefit the company.

Valuation and Investor Confidence

• 📉 Bernstein has lowered its price target for UnitedHealth Group but still maintains an outperform rating, indicating substantial upside potential.
• ⚠️ Significant execution issues have shaken investor confidence, leading to underperformance in results and a depressed stock price.
• 📊 The stock is trading at approximately 11 times forward earnings, which is viewed as an attractive valuation given the potential for recovery.

Medicare Advantage Challenges and Opportunities

• ⚠️ UnitedHealth has experienced challenges in Medicare Advantage, including higher-than-expected costs due to high utilization and significant rate cuts in 2024 and 2025.
• 📈 A more attractive rate increase is expected for 2026, coupled with a withdrawal of competition, which should lead to improved pricing cycles and margins.
• 🎯 The company has ample opportunity to fix pricing expectations and focus on margins for 2026, with bids due around June 1st.

Management and Future Outlook

• 🔄 The return of the former CEO and chairman, Steve, signals a potential reset of expectations and a renewed focus on operational improvements.
• 📈 This strategic reset is expected to set the stage for outsized EPS growth in 2026 and potentially for the three years through 2028.
• 🧩 Bernstein has significantly discounted each component part of the business due to a lack of management credibility, but sees a path to recovery.